Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-8-14
|
pubmed:abstractText |
The clinical and serologic findings in 25 patients with rheumatoid arthritis (RA) of more than 5 years' duration, who had antibodies to Ro(SSA) cellular antigen, were analyzed and compared with those in 50 anti-Ro(SSA) negative RA patients with similar disease duration. Ninety-six percent of the anti-Ro(SSA) positive patients were female, compared to 74% in the negative group. The majority of antibody positive patients had symmetric erosive synovitis, similar to that observed in the negative group. Extra-articular manifestations were similar in both groups, except for features of Sjögren's syndrome (keratoconjunctivitis sicca and positive labial salivary gland biopsy), which were significantly more common in patients with anti-Ro(SSA) antibodies. Anemia of chronic disease was also more common in these patients, as were rheumatoid factor (RF) and antinuclear antibodies (ANAs). No patient in either group had antibodies to ds-DNA or Sm and none developed clinical features suggestive of systemic lupus erythematosus (SLE). D-penicillamine, given in the majority of patients in both groups, produced adverse reactions in 72% of the anti-Ro(SSA) positive patients, but only in 27% of the negative ones. Thus, anti-Ro(SSA) antibodies seem to characterize a distinct group of RA patients who are almost exclusively female, express more activated B-cell function, have a high prevalence of Sjögren's features and commonly develop side effects to D-penicillamine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0896-8411
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
381-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3266995-Adult,
pubmed-meshheading:3266995-Aged,
pubmed-meshheading:3266995-Antibodies, Antinuclear,
pubmed-meshheading:3266995-Arthritis, Rheumatoid,
pubmed-meshheading:3266995-Greece,
pubmed-meshheading:3266995-Humans,
pubmed-meshheading:3266995-Lupus Erythematosus, Systemic,
pubmed-meshheading:3266995-Middle Aged,
pubmed-meshheading:3266995-Penicillamine,
pubmed-meshheading:3266995-Sjogren's Syndrome
|
pubmed:year |
1988
|
pubmed:articleTitle |
Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis.
|
pubmed:affiliation |
Department of Internal Medicine, School of Medicine, University of Ioannina, Greece.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|